IMX Ims Maxims

    Tuesday 8th May

                     IMS MAXIMS plc ("IMS" or the "Group")                     

                 Trading Update for year ending 31 March 2007                  

IMS MAXIMS plc (AIM: IMX) is pleased to provide an update on pre-audited
trading for the year ending 31 March 2007.

Trading for the year ending 31 March 2007 has seen continued growth as
demonstrated in the prior year. This is the result of increased revenue arising
from our satisfactory performance under our contract to supply IMS clinical
applications at Barking, Havering and Redbridge NHS Trust and, whilst we have
seen a moderate growth in operating expenses, the Group expects to report a
continued growth in operating profits before interest, taxation and minority
interests when the full year results are released in September 2007. Given the
Group decision to utilise debt to finance our continued investment in clinical
solutions net interest payable has risen year-on-year in-line with our Interim
Results reported on 22 December 2006.

We remain committed to our core markets of hospitals in the UK and Ireland and
hope to be able to leverage off the success of our contract to supply clinical
applications at Barking, Havering and Redbridge NHS Trust to further drive
growth for the Group.


Enquiries to:

Brian Ennis                Stephen Casey
Chief Executive Officer    Financial Director

IMS Maxims Plc
Clara House
Glenageary Park
Co. Dublin
Ireland

Tel +353 1 2840555
Fax +353 1 2840829



END

Ims Maxims (LSE:IMX)
Historical Stock Chart
From Apr 2024 to May 2024

Ims Maxims (LSE:IMX)
Historical Stock Chart
From May 2023 to May 2024